A new study finds that GLP-1 weight-loss drugs such as Ozempic and Wegovy may alter PET-CT cancer scans, raising concerns about false positives and unnecessary treatment risks​A new study finds that GLP-1 weight-loss drugs such as Ozempic and Wegovy may alter PET-CT cancer scans, raising concerns about false positives and unnecessary treatment risks ​Latest News [ SOBAN NEWS: International and National ]
